THE US Food and Drug Administration has restricted the sale and distribution of Bayer's Essure implantable contraception device, after finding some women were not being adequately informed of the known risks associated with the product - more details at fda.gov.
The above article was sent to subscribers in Pharmacy Daily's issue from 10 Apr 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Apr 18